An Australian stem cell and regenerative medicine company
About Us
About Us
What We Do
Board Of Directors
Management
Scientific Advisors
Corporate Governance
Company History
Clinical Development
Graft-versus-host-disease
Osteoarthritis
Acute respiratory distress syndrome
Diabetic Wounds
Renal transplantation
Pre-clinical Development
Asthma
Heart Attack
Coronary Artery Disease
Brain Cancer
Sepsis
Critical Limb Ischemia
Idiopathic pulmonary fibrosis
Science & Technology
Cymerus Technology
About MSCs
About iPSCs
Science Publications
Investors
Stock Information
ASX Announcements
Financial Reports
Presentations
Corporate Governance
Analyst Research
Investor FAQs
Right to Receive Documents
Newsroom
FAQ
Company FAQs
Investor FAQs
Contact Us
ASX Announcements
30 Jan 2017
Information Required Under ASX Listing Rule 3.10.5A
30 Jan 2017
Appendix 3B-Completion of Placement
25 Jan 2017
Notice Under Section 708A
25 Jan 2017
Appendix 4C - quarterly
25 Jan 2017
Appendix 3B-Receipt of Funds & Issue of Shares to Fujifilm
22 Jan 2017
Cynata Successfully Completes Capital Raising
18 Jan 2017
Cynata & FUJIFILM Sign Strategic Partnership Agreement
29 Dec 2016
Proposed Fujifilm Development & Commercialisation Transaction
15 Dec 2016
Cynata's Clinical Study Approved in Australia
12 Dec 2016
Cynata Receives NHS HRA Approval for Clinical Study
09 Dec 2016
Change of Share Registry Address
29 Nov 2016
Cynata Files Further Patent Application
17 Nov 2016
Appendix 3Y x 4
17 Nov 2016
Appendix 3B
15 Nov 2016
Results of AGM
15 Nov 2016
AGM Presentation
15 Nov 2016
Cynata Receives $1.749m R&D Tax Incentive Refund
31 Oct 2016
Activities Report & Appendix 4C
16 Oct 2016
Efficacy for CYP MSC Technology in Preclinical Asthma Study
13 Oct 2016
Annual Report to Shareholders
13 Oct 2016
Notice of Annual General Meeting/Proxy Form
19 Sep 2016
UK Regulatory Authority Approves Cynata GvHD Clinical Trial
11 Sep 2016
Expiry of Unlisted Options
09 Sep 2016
Appendix 3Y-Stewart Washer
06 Sep 2016
Corporate Presentation
05 Sep 2016
CYP Determines not to proceed with Regience Investment Offer
05 Sep 2016
CYP & FUJIFILM Sign Non-Binding Terms Sheet
02 Sep 2016
Trading Halt Request
19 Aug 2016
Appendix 4G
19 Aug 2016
Appendix 4E & Financial Statements
17 Aug 2016
Expiry of Unlisted Options
31 Jul 2016
Cynata Files Application to Commence Phase 1 Clinical Trial
29 Jul 2016
Activities Report & Appendix 4C
29 Jun 2016
Cynata Receives Investment Offer from Regience
20 Jun 2016
Cynata Prepares for Phase 1 Clinical Trial
09 Jun 2016
Initial Director's Interest Notice
08 Jun 2016
Cynata Appoints Paul K Wotton Ph.D. to Board of Directors
08 May 2016
Cynata Enters Agreement with apceth GmbH & Co KK
05 May 2016
CYP Manufactures CT Product; Files Further Patent Application
02 May 2016
Decision to Grant Patent for Cymerus MSC Technology in Japan
29 Apr 2016
Cynata & Regience Extend Entitlement Period
06 Apr 2016
Compelling Results from Pre-Clinical Stem Cell Study in GvHD
02 Mar 2016
Cynata Enters Agreement for Strategic Alliance in Japan
15 Feb 2016
Cyanta Receives $930k R&D Tax Incentive Refund
27 Jan 2016
CYP Receives Favourable Advice from UK Regulatory Authority
11 Jan 2016
Cynata CLI Study Published in Peer Reviewed Journal
16 Dec 2015
Cynata Enters Letter of Intent for a Commercial Partnership
07 Dec 2015
Rodman & Renshaw Initiates Cynata Research Coverage
02 Dec 2015
CYP Enters Letter of Intent for Strategic Alliance in Japan
30 Nov 2015
Expiry of Unlisted Options
‹
1
2
3
4
5
6
7
8
9
10
11
›